Oxacillin-resistant Staphylococcus aureus endophthalmitis after ganciclovir intraocular implant

American Journal of Ophthalmology

Volumn 129, Issue 4, 2000, Pages 554-555

  Williamson, John C ^a   Virata, Steven R ^b   Raasch, Ralph H ^a   Kylstra, Jan A ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DEXAMETHASONE; GANCICLOVIR; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC RESISTANCE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS; ENDOPHTHALMITIS; HUMAN; IMPLANT; MALE; PRIORITY JOURNAL; RETINITIS; SHORT SURVEY; STAPHYLOCOCCUS AUREUS;

EID: 0034025786     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00479-1     Document Type: Article

References (3)

1. Chen S., Stroh E.M., Wald K., Jalkh A. Xanthomonas maltophilia endophthalmitis after implantation of sustained-release ganciclovir. Am J Ophthalmol. 114:1992;772-773.
2. Outman W.R., Levitz R.E., Hill D.A., Nightingale C.H. Intraocular penetration of rifampin in humans. Antimicrob Agents Chemother. 36:1992;1575-1576.
3. Wong K.W., DAmico D.J., Oum B.S., Baker P.A., Kenyon K.R. Intraocular penetration of rifampin after oral administration. Graefe′s Arch Clin Exp Ophthalmol. 228:1990;40-43.